Clinical Trials on Limb-Girdle Muscular Dystrophy Type 2 in Korea, Democratic People's Republic of
Total 33 results
-
Yonsei UniversityCompletedSymptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)Korea, Republic of
-
Yonsei UniversityUnknownSymptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)Korea, Republic of
-
Boryung Pharmaceutical Co., LtdRecruitingType 2 Diabetes Mellitus | Essential HypertensionKorea, Republic of
-
Eulji University HospitalCompletedType 2 DiabetesKorea, Republic of
-
GuerbetCompletedType 2 Diabetes Mellitus | Coronary AtherosclerosisKorea, Republic of
-
SanofiCompletedType 2 Diabetes MellitusKorea, Republic of
-
Yuhan CorporationCompletedType 2 Diabetes Mellitus | Atherosclerotic Cardiovascular DiseaseKorea, Republic of
-
Seoul St. Mary's HospitalCompletedCoronary Artery Disease | Cardiovascular Disease | Atherosclerosis | Asymptomatic Patients With Type 2 Diabetes MellitusKorea, Republic of
-
Korea UniversityCompletedAtherosclerosis | Type 2 DiabetesKorea, Republic of
-
Boryung Pharmaceutical Co., LtdCompletedType 2 Diabetes Mellitus | Essential HypertensionKorea, Republic of
-
Seoul National University Bundang HospitalCompletedType 2 Diabetes Mellitus | Carotid AtherosclerosisKorea, Republic of
-
Korea UniversityWithdrawnAtherosclerosis | Type 2 DiabetesKorea, Republic of
-
Boryung Pharmaceutical Co., LtdRecruitingHypertension | Diabetes MellitusKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyMerck Ltd.CompletedHypertension | Diabetes Mellitus, Type IIKorea, Republic of
-
Seoul National University Bundang HospitalSamjin Pharmaceutical Co., Ltd.Recruiting
-
Yuhan CorporationUnknownType 2 Diabetes | Atherosclerotic Cardiovascular DiseaseKorea, Republic of
-
Newcastle-upon-Tyne Hospitals NHS TrustJain FoundationActive, not recruitingDysferlinopathy | LGMD2B Now Classified as LGMDR2 | Miyoshi MyopathyKorea, Republic of, Chile, Spain, United States, Denmark, France, Italy, Japan, United Kingdom
-
AutotelicbioRecruitingDiabetes Mellitus, Type 2 | Essential HypertensionKorea, Republic of
-
Seoul National University Bundang HospitalCompletedHypertension | Diabetes Mellitus, Type 2 | Angiotensin/Renin/Aldosterone HypertensionKorea, Republic of
-
Chonbuk National University HospitalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Seoul National University Bundang HospitalRecruitingHypertension | Diabetes Mellitus, Type 2 | Atherosclerosis | Renin HypertensionKorea, Republic of
-
Kiyuk ChangSeoul St. Mary's Hospital; Pusan National University Hospital; Korea University... and other collaboratorsRecruitingMyocardial Infarction | Diabetes Mellitus, Type 2Korea, Republic of
-
AstraZenecaCompletedEffect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (PATROL)Hypertension | Hyperlipidemia | GlycemiaKorea, Republic of
-
Seoul National University Bundang HospitalDaewon Pharmaceutical Co., Ltd.RecruitingDiabetes Mellitus, Type 2 | Atherosclerosis | DyslipidemiaKorea, Republic of
-
Seoul National University Bundang HospitalKorea United Pharm. Inc.RecruitingDiabetes Mellitus, Type 2 | Atherosclerosis | DyslipidemiasKorea, Republic of
-
Chung-Ang UniversityUnknownDiabetes Mellitus, Type 2 | Acute Coronary SyndromeKorea, Republic of
-
Tehran University of Medical SciencesCompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | Essential HypertensionIran, Islamic Republic of
-
AstraZenecaCompletedHypertensionKorea, Republic of
-
Baqiyatallah Medical Sciences UniversityCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
-
The George InstituteServierCompletedDiabetes Mellitus, Type 2Australia, Canada, China, Czech Republic, Estonia, France, Germany, Hungary, India, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Philippines, Poland, Russian Federation, Slovakia, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, France, Spain, Sweden, China, Korea, Republic of, United States, Canada, Germany, Ireland, Mexico, Poland, India, Denmark, Hungary, United Kingdom, New Zealand, Malaysia, Netherlands, Russian Federation, Thailand, Romania, Ita... and more
-
TakedaCompletedDiabetes Mellitus, Type 2 | Acute Coronary SyndromeUnited States, France, Italy, Poland, Ukraine, United Kingdom, Belgium, Germany, Hong Kong, Argentina, Chile, Colombia, Israel, Mexico, Portugal, Bulgaria, Malaysia, Romania, Serbia, South Africa, Japan, Canada, Finland, Taiwan, Korea,... and more